Biotechgate Digital Partnering August 2026

Biotechgate Digital Partnering August 2026
Go back

BIOTECHGATE DIGITAL PARTNERING

Virtual business development & licensing event | Aug 31 – Sep 4, 2026

Biotechgate Digital Partnering is focusing on companies developing drugs, diagnostics and medical devices. The main objective of the event is to provide a platform for business development in the field of licensing and collaboration.

CONFERENCE PROGRAM

Biotechgate Digital Partnering offers you a complete conference program as a virtual experience, including virtual one-on-one meetings, Pop-up Coffee sessions as well as workshops and presentations.

Digital Partnering

The scheduling of individual one-on-one meetings is provided by our premium partnering and matchmaking platform HelloPartnering.

  • 5 days of Digital Partnering: Contact and arrange meetings with representatives of leading companies active in the Biotech and Pharma industry. See who is attending »
  • Attend your pre-scheduled meetings via Zoom video calls. Learn more about the partnering »
  • Privacy is guaranteed: Every virtual meeting takes place in its own, secure virtual room.
Free registration

To support the business development in the Biotech, Medtech and Pharma industry, we are making this partnering event available for free to companies interested in participating. As a member company of any of our Biotechgate partners, you get free Premium Access to Biotechgate Digital Partnering. If you are not a member of any of our partners, you still get free access with some limitations and a possibility to upgrade.

More details about the partnering are available in the FAQ and Registration sections further down on this page.

BioRN members receive a free Premium Access to Biotechgate Digital Partnering .

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

Researchers and physicians at the Hopp Children’s Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases. The individual compassionate-use treatment has now been […]

read more
Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]

read more
Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies (COS) at Heidelberg University have launched a new research project investigating so-called dipeptides. Some of these naturally occurring protein building blocks are able to neutralize toxic metabolic by-products and may therefore help protect against vascular and kidney damage, particularly […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp